Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Guangzhou Preterm and Term Birth Cohort Study (GPTBC)

30 października 2026 zaktualizowane przez: Li Cai, PhD, Sun Yat-sen University

The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a prospective observational study of how early-life nutrition, environmental exposures, and family factors relate to the health and development of preterm and term infants and their mothers. Mother-infant pairs are followed from birth to 24 months. Researchers use questionnaires and biological samples to study human milk, microorganisms in the infant gut, physical growth, development, and allergic diseases, and whether these relationships differ between preterm and term infants. Findings may inform nutrition and health strategies for infants born at different gestational ages.

Przegląd badań

Status

Aktywny, nie rekrutujący

Warunki

Interwencja / Leczenie

Szczegółowy opis

The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a single-center, prospective longitudinal observational study conducted at the Third Affiliated Hospital of Guangzhou Medical University. Mothers and their preterm or term infants were enrolled within 7 days after delivery and are followed primarily through 24 months of age; a subset receives additional follow-up beyond 24 months. The cohort was designed to recruit approximately equal numbers of preterm and term infants to characterize early-life exposures and health trajectories and to assess whether preterm birth modifies exposure-outcome associations.

The primary scientific focus is how human milk composition and other early-life nutritional and environmental exposures relate to infant growth, neuropsychological development, allergic diseases, and gut microbiome development. Serial human milk samples support measurements of nutritional components, 23 targeted human milk oligosaccharides, selected bioactive proteins, fatty acids, metabolomic and lipidomic profiles, microbial metagenomes, and exposomic profiles of environmental contaminants. Infant stool samples are analyzed using metagenomic sequencing. Additional stored biospecimens support related current and future research.

Repeated questionnaires capture maternal postpartum health, diet, lifestyle, psychological status, medication use, and breastfeeding; infant feeding, supplementation, illness, medication use, sleep, activity, screen exposure, and caregiving environment; and selected paternal and family characteristics. Child health is assessed longitudinally using anthropometry, standardized developmental assessments, eye tracking, parental reports of physician-diagnosed allergic diseases, and microbiome measures.

The study will examine exposure patterns and their changes over time, associations with maternal and child health, potential biological pathways, and differences between preterm and term infants.

Typ studiów

Obserwacyjny

Zapisy (Szacowany)

200

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

    • Guangdong
      • Guangzhou, Guangdong, Chiny, 510000
        • Sun Yat-sen University

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat do 45 lat (Dorosły)

Akceptuje zdrowych ochotników

Tak

Płeć kwalifikująca się do nauki

Wszystko

Metoda próbkowania

Próbka bez prawdopodobieństwa

Badana populacja

Mother-infant pairs (term and preterm).

Opis

Inclusion Criteria:

  1. Maternal age between 18 and 45 years.
  2. Resident in Guangzhou for at least one year.
  3. Gestational age at delivery ≥ 32 weeks and < 42 weeks (moderate-to-late preterm or term births).

Exclusion Criteria:

  1. Critical illness during pregnancy requiring admission to the intensive care unit.
  2. Unwilling or unable to breastfeed.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Modele obserwacyjne: COHORT
  • Perspektywy czasowe: PROSPECTIVE

Kohorty i interwencje

Grupa / Kohorta
Interwencja / Leczenie
Preterm Birth Group

Mother-infant pairs in which the infant was born at 32 weeks 0 days to 36 weeks 6 days of gestation.

This cohort study have any no intervention.

Term Birth Group

Mother-infant pairs in which the infant was born at 37 weeks 0 days to 41 weeks 6 days of gestation.

This cohort study have any no intervention.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Offspring Length/Height (cm)
Ramy czasowe: Birth, 1 months, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.

Offspring length or height measured by a pediatrician.

Birth, 1 months, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
Offspring Weight (kg)
Ramy czasowe: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Offspring weight measured using a calibrated scale.

Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
Offspring Head Circumference (cm)
Ramy czasowe: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Offspring head circumference measured by a pediatrician.

Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
Offspring Body Mass Index (kg/m²)
Ramy czasowe: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Calculated as weight (kg) divided by the square of length or height (in meters).

Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
Neurodevelopmental outcome - Gesell Developmental Schedules (GDS)
Ramy czasowe: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.

Developmental Quotients (DQ) for each developmental domain, assessed by the Gesell Developmental Schedules (GDS) administered by a pediatrician. DQ is calculated as (developmental age / chronological age or corrected age) × 100, with higher DQ indicating better development. Domains include: (1) adaptive, (2) gross motor, (3) fine motor, (4) language, and (5) personal-social.

1 month, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
Neurodevelopmental outcome - Ages and Stages Questionnaires (ASQ)
Ramy czasowe: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Parent-reported scores (0-60) for each developmental domain, assessed using the Ages and Stages Questionnaires (ASQ). Higher scores indicate better development. Domains include: (1) communication, (2) gross motor, (3) fine motor, (4) problem-solving, and (5) personal-social.

1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Social Cognitive Attention Patterns - Sufficient Fixation Trials (number)
Ramy czasowe: 6 months, 8 months, and 12 months of age.

Number of trials in which the fixation duration on specific Areas of Interest (social and non-social) exceeds 30% of the total fixation duration on the entire screen, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator indicates adequate attentional engagement with the presented social and non-social stimuli.

6 months, 8 months, and 12 months of age.
Social Cognitive Attention Patterns - First Fixation Count (number)
Ramy czasowe: 6 months, 8 months, 12 months of age.

Number of times the first fixation following stimuli onset lands on specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator captures initial attentional orienting and reflects the salience of the presented social and non-social stimuli.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - First Fixation Duration (seconds)
Ramy czasowe: 6 months, 8 months, 12 months of age.

Duration (in seconds) of the first fixation within specific Areas of Interest (social and non-social) following stimulus onset, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects early-stage attentional processing and the efficiency of initial stimulus engagement.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - Total Fixation Count (number)
Ramy czasowe: 6 months, 8 months, 12 months of age.

Total number of discrete fixation events occurring within specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects the overall frequency of attentional engagement with the presented social and non-social stimuli.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - Total Fixation Duration (seconds)
Ramy czasowe: 6 months, 8 months, 12 months of age.

Cumulative duration (in seconds) of all fixations occurring within specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects overall attentional allocation to the presented social and non-social stimuli.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - Fixation Duration Proportion (%)
Ramy czasowe: 6 months, 8 months, 12 months of age.

Percentage of total fixation time allocated to social or non-social Areas of Interest, calculated as (total fixation time on social or non-social Areas of Interest / total fixation time on all Areas of Interest) × 100, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects relative attentional preference between social and non-social stimuli.

6 months, 8 months, 12 months of age.
Number of Participants with Physician-Diagnosed Allergic Diseases
Ramy czasowe: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Number of participants who experience at least one episode of physician-diagnosed allergic diseases during the follow-up period, including eczema or atopic dermatitis, cow's milk protein allergy, other food allergies, allergic rhinitis, and asthma, as diagnosed by a physician and reported by parents, and confirmed by medical records.

1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Współpracownicy

Śledczy

  • Główny śledczy: Li Cai, Ph.D, Sun Yat-sen University
  • Główny śledczy: Lizi Lin, Ph.D, Sun Yat-sen University

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

21 listopada 2023

Zakończenie podstawowe (Szacowany)

31 grudnia 2026

Ukończenie studiów (Szacowany)

31 grudnia 2026

Daty rejestracji na studia

Pierwszy przesłany

14 kwietnia 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

5 sierpnia 2026

Pierwszy wysłany (Rzeczywisty)

10 sierpnia 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

3 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

30 października 2026

Ostatnia weryfikacja

1 października 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • GPTBC

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIEZDECYDOWANY

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .